PM
ProMIS Neurosciences
PMN·NASDAQToronto CAFounded 200410 employees
Micro CapbiotechPublicNeurology
Platform: PMN310 AD
Market Cap
$0.1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PMN)
Loading PMN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Suramavacamten | PMN-1658 | Phase 1 | 1 | TROP-2 | UCPNH | ||
| Doxafutibatinib | PMN-8834 | Phase 1 | 1 | MDM2 | MG |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)